192 related articles for article (PubMed ID: 33291073)
1. Identification of a novel and potent small molecule inhibitor of SRPK1: mechanism of dual inhibition of SRPK1 for the inhibition of cancer progression.
Chandra A; Ananda H; Singh N; Qamar I
Aging (Albany NY); 2020 Dec; 13(1):163-180. PubMed ID: 33291073
[TBL] [Abstract][Full Text] [Related]
2. Identification of hot spot residues on serine-arginine protein kinase-1 by molecular dynamics simulation studies.
Chandra A; Goyal N; Qamar I; Singh N
J Biomol Struct Dyn; 2021 Mar; 39(5):1579-1587. PubMed ID: 32093544
[TBL] [Abstract][Full Text] [Related]
3. SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors.
Colwill K; Feng LL; Yeakley JM; Gish GD; Cáceres JF; Pawson T; Fu XD
J Biol Chem; 1996 Oct; 271(40):24569-75. PubMed ID: 8798720
[TBL] [Abstract][Full Text] [Related]
4. Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2.
Ngo JC; Chakrabarti S; Ding JH; Velazquez-Dones A; Nolen B; Aubol BE; Adams JA; Fu XD; Ghosh G
Mol Cell; 2005 Oct; 20(1):77-89. PubMed ID: 16209947
[TBL] [Abstract][Full Text] [Related]
5. Regiospecific phosphorylation control of the SR protein ASF/SF2 by SRPK1.
Ma CT; Hagopian JC; Ghosh G; Fu XD; Adams JA
J Mol Biol; 2009 Jul; 390(4):618-34. PubMed ID: 19477182
[TBL] [Abstract][Full Text] [Related]
6. The subcellular localization of SF2/ASF is regulated by direct interaction with SR protein kinases (SRPKs).
Koizumi J; Okamoto Y; Onogi H; Mayeda A; Krainer AR; Hagiwara M
J Biol Chem; 1999 Apr; 274(16):11125-31. PubMed ID: 10196197
[TBL] [Abstract][Full Text] [Related]
7. Processive phosphorylation of alternative splicing factor/splicing factor 2.
Aubol BE; Chakrabarti S; Ngo J; Shaffer J; Nolen B; Fu XD; Ghosh G; Adams JA
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12601-6. PubMed ID: 14555757
[TBL] [Abstract][Full Text] [Related]
8. A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding.
Cao W; Garcia-Blanco MA
J Biol Chem; 1998 Aug; 273(32):20629-35. PubMed ID: 9685421
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1.
Ma CT; Ghosh G; Fu XD; Adams JA
J Mol Biol; 2010 Oct; 403(3):386-404. PubMed ID: 20826166
[TBL] [Abstract][Full Text] [Related]
10. Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor.
Labourier E; Rossi F; Gallouzi IE; Allemand E; Divita G; Tazi J
Nucleic Acids Res; 1998 Jun; 26(12):2955-62. PubMed ID: 9611241
[TBL] [Abstract][Full Text] [Related]
11. Adaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1.
Hagopian JC; Ma CT; Meade BR; Albuquerque CP; Ngo JC; Ghosh G; Jennings PA; Fu XD; Adams JA
J Mol Biol; 2008 Oct; 382(4):894-909. PubMed ID: 18687337
[TBL] [Abstract][Full Text] [Related]
12. A novel Physarum polycephalum SR protein kinase specifically phosphorylates the RS domain of the human SR protein, ASF/SF2.
Liu S; Kang K; Zhang J; Ouyang Q; Zhou Z; Tian S; Xing M
Acta Biochim Biophys Sin (Shanghai); 2009 Aug; 41(8):657-67. PubMed ID: 19657567
[TBL] [Abstract][Full Text] [Related]
13. Functional coexpression of serine protein kinase SRPK1 and its substrate ASF/SF2 in Escherichia coli.
Yue BG; Ajuh P; Akusjärvi G; Lamond AI; Kreivi JP
Nucleic Acids Res; 2000 Mar; 28(5):E14. PubMed ID: 10666475
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
15. Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis.
Nowak DG; Amin EM; Rennel ES; Hoareau-Aveilla C; Gammons M; Damodoran G; Hagiwara M; Harper SJ; Woolard J; Ladomery MR; Bates DO
J Biol Chem; 2010 Feb; 285(8):5532-40. PubMed ID: 19906640
[TBL] [Abstract][Full Text] [Related]
16. Ordered multi-site phosphorylation of the splicing factor ASF/SF2 by SRPK1.
Ma CT; Velazquez-Dones A; Hagopian JC; Ghosh G; Fu XD; Adams JA
J Mol Biol; 2008 Feb; 376(1):55-68. PubMed ID: 18155240
[TBL] [Abstract][Full Text] [Related]
17. Allosteric interactions direct binding and phosphorylation of ASF/SF2 by SRPK1.
Huynh N; Ma CT; Giang N; Hagopian J; Ngo J; Adams J; Ghosh G
Biochemistry; 2009 Dec; 48(48):11432-40. PubMed ID: 19886675
[TBL] [Abstract][Full Text] [Related]
18. Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target.
Kurimchak AM; Kumar V; Herrera-Montávez C; Johnson KJ; Srivastava N; Davarajan K; Peri S; Cai KQ; Mantia-Smaldone GM; Duncan JS
Mol Cell Proteomics; 2020 Dec; 19(12):2068-2090. PubMed ID: 32994315
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2.
Prescott EL; Brimacombe CL; Hartley M; Bell I; Graham S; Roberts S
J Virol; 2014 Nov; 88(21):12599-611. PubMed ID: 25142587
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors.
Gui JF; Tronchère H; Chandler SD; Fu XD
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10824-8. PubMed ID: 7526381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
